Plaisance Capital Management
Overview
Plaisance Capital Management is a biotech-focused investment management company that discovers, nurtures, and invests in promising biotech startups, providing them with resources, mentorship, and capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Reunion Neuroscience Inc. | May 2024 | Series A | Co-investor |
| Perceptive Technologies | Jul 2024 | Series B | Co-investor |
| BlossomHill Therapeutics | Feb 2024 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Plaisance Capital Management based?
Plaisance Capital Management is headquartered in Cambridge, Massachusetts, United States.
When was Plaisance Capital Management founded?
Plaisance Capital Management was founded in 2020.
How many portfolio companies does Plaisance Capital Management have?
Plaisance Capital Management has 3 portfolio companies in Caplight's dataset.
What are some companies in Plaisance Capital Management's portfolio?
Portfolio companies visible on Caplight include Reunion Neuroscience Inc., Perceptive Technologies, BlossomHill Therapeutics.
What was Plaisance Capital Management's most recent investment shown here?
Plaisance Capital Management's most recent investment in this portfolio sample was in Perceptive Technologies in 2024.
What sectors does Plaisance Capital Management focus on?
Plaisance Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Plaisance Capital Management focus on?
Plaisance Capital Management typically invests at the Mid stage.